echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Cell Prolif︱Lai Liangxue/Zhang Kun/Zou Qingjian team successfully constructed a technical system for safe and efficient directional induction of motor neurons in vivo

    Cell Prolif︱Lai Liangxue/Zhang Kun/Zou Qingjian team successfully constructed a technical system for safe and efficient directional induction of motor neurons in vivo

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Written by Chen Min

    Editor in charge ︱ Wang Sizhen

    Editor︱Yang Binwei


    The death of specific motor neurons is the most typical and direct pathological feature of motor neuron disease



    On August 10, 2022, researcher Lai Liangxue's team from Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Professor Zhang Kun's team and Associate Professor Zou Qingjian's team from Wuyi University's School of Biotechnology and Big Health jointly published an article entitled "Inducible motor neuron" on Cell Proliferation.




    The authors firstly transferred two PB vectors (①PB-NIL: conditionally expressing motor neuron transcription factor Ngn2-Isl1-Lhx3; ②PB-BLG overexpressing anti-apoptotic gene Bcl-xL and marker genes Luciferase, EGFP) into hiPSCs , two positive cell clones, NIL-hiPSCs (transfected with PB-NIL only) and NILB-hiPSCs (transfected with PB-NIL+PB-BLG at the same time) were obtained by antibiotic screening (Fig.



    Fig.


    (Source: Min Chen et al.



    Interestingly, extending the culture time beyond 2 weeks, the authors observed the generation of a population of non-neuronal cells among the mature neurons; this population of cells abundantly expressed the neural precursor cell markers SOX2, PAX6, and the proliferation marker Ki67 , while forming a typical neural rosette-like structure



    Figure 2 Long-term differentiation of NILB-hiPSCs to generate neural precursor cells

    (Image source: Min Chen et al.



    The authors directly injected NILB-hiPSCs into the subcutaneous tissue of immunodeficient mice to investigate in vivo differentiation
    .

    The expression of Ngn2, Isl1 and Lhx3 was induced by intraperitoneal injection of Dox (25 mg/kg, 5 days), and the uninduced group was given the same amount of PBS
    .

    In vivo imaging results showed that the activity of Luciferase in the uninduced group increased rapidly with time, and undifferentiated hiPSCs proliferated rapidly in the subcutaneous tissue
    .

    In contrast, the activity of Luciferase in the Dox-induced group decreased rapidly with time, and finally disappeared at the 8th week (Fig.
    3A)
    .

    The above experimental results show that Dox-induced subcutaneous injection of NILB-hiPSCs will not form teratoma, and its safety is high
    .

    In addition, the authors identified the subcutaneous cell clumps by immunofluorescence, and found that the transplanted NILB-hiPSCs were mainly in the direction of neural differentiation subcutaneously, and abundantly expressed motor neuron-related markers TUJ1, MAP2, HB9 and ChAT (Fig.
    3B)
    .

    In samples from week 4, the authors observed a large number of chamber structures and expressed neural precursor cell markers SOX2 and PAX6, as well as proliferation marker Ki67 (Fig.
    3C)
    .

    To further investigate the subcutaneously differentiated cell types of NILB-hiPSCs, the authors removed the cell clumps at the 4th week of transplantation and cultured them in vitro (Fig.
    3D)
    .

    Primary cells also formed a rosette-like structure and expressed neural precursor cell markers SOX2 and PAX6 (Figure 3E); at the same time, they could differentiate into motor neurons quickly and efficiently without the addition of Dox motor neuron induction medium (Figure 3E).
    3F), consistent with the experimental phenomenon observed in vitro
    .

    Figure 3 In vivo differentiation of NILB-hiPSCs injected subcutaneously

    (Image source: Min Chen et al.
    , Cell Proliferation, 2022)

    In motor neuron disease, motor neurons in the spinal cord of patients die extensively, so the authors injected NILB-hiPSCs into the spinal cord tissue of immunodeficient mice to investigate their survival and differentiation
    .

    Similar to the subcutaneous injection, cells transplanted into the spinal cord decreased substantially in the first 2 weeks, but the number of cells rebounded by week 4, and then stably survived until week 20 (Fig.
    4A and B)
    .

    The results of immunofluorescence staining showed that NILB-hiPSCs formed synapses and other structures in the mouse spinal cord; and a large number of cells expressed neuronal markers TUJ1, MAP2, HB9 and ChAT (Fig.
    4C)
    .

    More importantly, the transplanted cells integrated into mouse spinal cord tissue and generated strong action potentials and ionic currents (Fig.
    4D)
    .

    It indicated that NILB-hiPSCs could differentiate into functionally mature motor neurons in spinal cord tissue
    .

    Similar to subcutaneous transplantation, cells injected into the spinal cord also formed chamber-like structures and expressed neural precursor cell markers SOX2 and PAX6 (Fig.
    4E), and proliferation marker Ki67 (Fig.
    4F), indicating that the transplanted cells were in the spinal cord can continue to multiply
    .

    Unexpectedly, a small fraction of cells also expressed OLIG2 (Fig.
    4G), indicating further differentiation of neural precursor cells into motor neuron precursor cells
    .

    The above results demonstrate that the transplanted cells can survive in spinal cord tissue for 5 months and differentiate into a mixed cell population of motor neurons, neural precursor cells, and motor neuron precursor cells
    .

    Figure 4 In vivo differentiation of NILB-hiPSCs injected into spinal cord

    (Image source: Min Chen et al.
    , Cell Proliferation, 2022)

    Conclusion and Discussion, Inspiration and Prospects In summary, this study combined in vitro gene modification of stem cells with in vivo induction and differentiation technology for the first time, and successfully constructed a technical system for efficient and directional induction of motor neurons in vivo
    .

    In the follow-up, in-depth research will focus on the therapeutic effect of NILB-hiPSCs on MNDs animal models
    .

    More importantly, hiPSCs can differentiate into various types of somatic cells through transcription factors, if Ngn2-Isl1-Lhx3 is replaced by other cell-specific transcription factors (such as liver-specific transcription factors Foxa3-Hnf1A-Hnf4A, kidney-specific transcription factors Sex transcription factor Six2), can induce various types of functional cells in vivo, and then used for transplantation therapy of corresponding diseases
    .

    It can be seen that this study not only provides a new strategy for MNDs stem cell therapy, but also has important value and significance for other diseases
    .

    However, because the transposon vector used in this study may integrate foreign genes into key positions in the genome, it may cause safety concerns such as stem cell carcinogenesis or uncontrollable differentiation process
    .

    In another recently published article, the team introduced drugs to induce the suicide of pluripotent stem cells to remove undifferentiated cells in the body, which to a certain extent improved the safety of stem cell therapy in vivo [5]
    .

    In the future, site-specific integration of exogenous genes can also be used to minimize the safety risks brought by transgenes to cell therapy
    .

    Original link: https://onlinelibrary.
    wiley.
    com/doi/10.
    1111/cpr.
    13319

    Researcher Lai Liangxue, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Associate Professor Zou Qingjian and Professor Zhang Kun from the School of Biotechnology and Big Health, Wuyi University are the co-corresponding authors of the paper, Dr.
    Chen Min from the School of Biotechnology and Big Health, Wuyi University, Master Li Chuan and Wang Xia of the Bio Island Laboratory are the co-first authors of the paper
    .

    Selected past articles

    【1】Nat Commun︱Peng Yueqing's team discovered a new brain area that controls non-REM sleep

    【2】eClinicalMedicine︱Wang Qing’s team reported Parkinson’s disease dementia related index determination: quantitative EEG, serum metabolism and inflammation

    【3】Cell Biosci | Wang Yongjun's research group revealed the molecular mechanism of D-type dopachrome isomerase-mediated inflammatory response in injured spinal cord

    【4】Neuron|Hu Yang's group revealed a large number of genes that promote optic nerve regeneration and their significant neuroprotective effects in glaucoma mice

    【5】Cereb Cortex︱Zhang Yuxuan's research group reveals the neurophysiological evidence of task modulation in speech processing

    [6] Trends Cogn Sci︱Jiang Qiu team writes opinion articles on creative problem solving in knowledge-rich fields

    【7】Front Aging Neurosci︱Hongmei Yu's team constructed a hierarchical multi-classification diagnosis framework for AD based on imaging features and clinical information

    【8】J Neurosci︱Jin Mingyue/Guangchang Shinji's team revealed that α-Syn and tau play an important synergistic physiological function during brain development

    【9】Cell Death Differ︱Xia Xiaobo's team revealed for the first time the relationship between "iron death" and the pathogenesis of glaucoma

    【10】Sci Adv︱ Zeng Kewu/Tu Pengfei's team revealed a new target for the regulation of neuroinflammation by active ingredients of traditional Chinese medicine Yemazhui

    Recommended high-quality scientific research training courses

    [1] Symposium on Single-Cell Sequencing and Spatial Transcriptomics Data Analysis (August 27-28, Tencent Online Conference)

    【2】Training course︱R language clinical prediction biomedical statistics special training

    [3] Workshop on Metagenomics and Metabolomics R Language Analysis and Visualization (Tencent Conference on August 27)

    Forum/Seminar Preview

    【1】Forum Preview︱Brain·Machine Intelligence Fusion——Let the brain connect to the future, the brain science theme forum is the first time!

    Welcome to "Logical Neuroscience" [1] Talent Recruitment︱"Logical Neuroscience" is looking for article interpretation/writing positions (part-time online, online office)

    References (swipe up and down to read) 

    1 Wyatt T J, Rossi S L, Siegenthaler M M, et al.
    Human motor neuron progenitor transplantation leads to endogenous neuronal sparing in 3 models of motor neuron loss.
    Stem cells international, 2011, 2011.

    2 Xu L, Yan J, Chen D, et al.
    Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats.
    Transplantation, 2006, 82(7): 865-875.

    3 Popescu I R, Nicaise C, Liu S, et al.
    Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.
    Stem cells translational medicine, 2013, 2(3): 167-174

    4 Itzhak F, Jennifer N D, Michael A L.
    Transplanting neural progenitor cells to restore connectivity after spinal cord injury, Nature Review Neuroscience, 2020, 21(7): 366-383

    5 Liu Y, Yang Y, Suo Y, et al.
    Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy.
    Mol Ther Methods Clin Dev, 2022, 24: 332-41


    End of this article
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.